series-c-plus
Stage
2
Investors
About
InflaRx is a clinical-stage biopharmaceutical company developing novel therapeutics to treat life-threatening inflammatory conditions. Their approach involves targeting the complement system.
Explore InflaRx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.